drugset / Trial / NCT01728337
Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum
RandomizedParallel-groupDouble-blindTreatment
Summary
this study was proposed to provide more scientific and objective data on the clinical and aesthetic effects of these two toxins (Dysport and Xeomin).
Timeline
- Start
- 2011-07
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 12 iu | — |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 30 iu | — |
Indications
No indication recorded.